Wen Li focuses her practice on patent prosecution in the pharmaceutical and chemical areas. Wen’s experience includes managing worldwide patent portfolios for pharmaceutical companies. Her practice also includes patent litigation, due diligence investigations, patentability/infringement opinion drafting and client counseling.
Wen previously worked as a senior/principal medicinal chemist in a biopharmaceutical company, where she gained experience in designing and synthesizing small molecule antagonists for GPCRs and Integrin receptors. Wen was a named inventor in several patents in these fields. In addition to having an in-depth understanding of and/or hands-on experience in small molecule chemistry, peptide/protein chemistry and polymer chemistry, she also has a deep understanding of concepts concerning bioavailability, which include Cmax, AUC and ADME. She applies her background by working with expert witnesses, particularly in areas concerning small molecules, XRPD, HPLC and NMR.
Articles in the National Law Review database by Wen Li